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. Preliminary study: Positions of selected heterozygous sequence variants detected by Sanger sequencing in our region of interest (exons with -50-bp and +20-bp flanking intronic sequences) as a function of the GC content of 30-bp flanking sequences. (A) Occurrence of variants in the designed target region of each platform. (B) Platforms providing ≥20 reads at heterozygous variant positions. Note that, contrary to expectations, not all exonic positions are within the designed target region of the Agilent platform. Furthermore, none of the two platforms achieved complete coverage of all exonic positions at ≥20 reads. Exonic positions are given in percentage [%] relative to the length of the corresponding exon, whereas intronic positions are given as absolute positions in base pairs [bp] . SS, Agilent SureSelect v4+UTR; NG, NimbleGen SeqCap v3; *, heterozygous in one additional DNA sample with the same symbol; **, heterozygous in two additional DNA samples with the same symbol; ***, heterozygous in three additional DNA samples with the same symbol. Figure S2 . Preliminary study: Read depth for 44 different SNV positions within our region of interest (coding exons and -50-bp and +20-bp flanking intronic sequences) called as heterozygous in at least one of the eight samples (the six samples from this study as well as 45 and 273) plotted against the GC content of 30-bp flanking sequences. (A) Agilent (SureSelect Human All Exon kit v4+UTR). (B) NimbleGen (SeqCap EZ Exome v3). Red dashed line indicates our limit of 20 reads. Note the high number of positions failed to reach the limit of 20 reads by the Agilent platform.
A B
A B Figure S3 . Comparison of enrichment efficiency for GC-rich exons in the six samples of the present study and 24 additional DNA samples. Integrative Genomics Viewer (IGV) print screens showing coverage track (0-20 reads) for KLF2 exons 1 and 2, KLF15 exon 3, and TGFBR1 exon 1, which have high GC content. (A, B) DNA samples extracted from blood. (C) DNA samples extracted from saliva 7739) or fibroblasts (326) . For the six samples of this study (44, 280, 326, 2905, 7344, 7739) , WES data of V2 using Agilent SureSelect v5+UTR at 100× are shown. The additional 24 samples (DNA 1-24) were sequenced by V2 using Agilent SureSelect v5 at 60×. *, designed target region of Agilent SureSelect v5; **, designed target region of Agilent SureSelect v5+UTR.
A B C
Although DNA samples extracted from blood performed slightly better, no distinct performance difference among the 24 additional DNA samples sequenced at 60× using Agilent was observed in selected GC-rich exons of KLF2, KLF15, and TGFBR1, confirming our observations on the six samples sequenced at 100× using Agilent. Unexpectedly, for one extremely GC-rich (83%) exon, which was not covered sufficiently even when sequenced at 100×, one DNA extracted from saliva and sequenced at 60× achieved a mean of 18 reads (TGFBR1 in DNA 21). Figure S4 . Schematic presentation of terms used in this study. SV, sequence variant; *insufficient coverage e.g. due to GC-rich regions or distance to hybridisation probes; closed lines, regions with defined length and positions; open lines, regions with variable length and positions. Note that according to Agilent's definition the designed target region is completely covered by hybridisation probes (cf. platform 1), whereas NimbleGen and Illumina define it as the region intended/designed to be enriched (cf. platform 2). Figure S6 ). Note that all exonic positions are in designed target regions and completely covered by all three enrichment platforms with ≥20 reads and that Agilent and particularly Illumina covered variants outside its designed target region with ≥20 reads. Exonic positions are given in percentages [%] relative to the length of the corresponding exon, whereas intronic positions are given as absolute positions in base pairs [bp] . SS, Agilent SureSelect v5+UTR; NG, NimbleGen SeqCap v3+UTR; NEX, Illumina Nextera Expanded Exome; *, heterozygous in one additional DNA sample with the same symbol; **, heterozygous in two additional DNA samples with the same symbol. 
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All ≥20 reads and in TR SS and NG ≥20 reads, all in TR NEX ≥20 reads, NG and NEX in TR * * Figure S7 . Enrichment performance per vendor for DNA samples with selected heterozygous sequence variants detected by Sanger sequencing in UTR as a function of the GC content of 30-bp flanking sequences. (A) Results of the same vendor for all platforms (V1). (B) Data of different vendors (V2-V4). Positions of variants are given as distance to coding region in base pairs [bp] (i.e. -50 to -1 for 5'UTR and 1 to 750 for 3'UTR). TR, designed target region; SS, Agilent SureSelect v5+UTR; NG, NimbleGen SeqCap v3+UTR; NEX, Illumina Nextera Expanded Exome; *, heterozygous in one additional DNA sample with the same symbol. Note that one variant position in a GC-rich (82%) exon (orange) is located within the designed target region of both NimbleGen (NG) and Illumina (NEX) but is only covered by Illumina (NEX) at 20× (regardless of vendor).
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A B Agilent_V1   0   40   80   120   160   200   240   20  25  30  35  40  45  50  55  60  65  70  75 Figure S9 . Read depth of all five WGS data sets for 30 different SNV positions within our region of interest (coding exons and -50-bp and +20-bp flanking intronic sequences) and five in UTR plotted against the GC content of 30-bp flanking sequences. Green dashed lines indicate expected read depth of 60 and 30 (reads), respectively, and red dashed line denotes read depth of 20 (reads). Note that at 30× V4 performed better than V3 and that only WGS data at 60× (V1 and V4_X Ten) reached for all positions the limit of 20 reads (cf. Supplementary Figure S17 ). X Ten, HiSeq X Ten system. 
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Unaligned reads
Mapped duplicated reads
Mapped reads without duplicates Figure S13 . Reads generated using the three different enrichment platforms (Agilent, NimbleGen, and Illumina) applied by different vendors. (A, B) Number of unaligned reads, mapped duplicated reads, and remaining reads used for analysis (mapped reads without duplicates) according to BAM files provided by vendors (A) and in-house generated BAM files using the same bioinformatics pipeline (B). *Note that bioinformatics workflow is different among vendors and that vendor 3 and vendor 4 provided unique mapped reads in contrast to total mapped reads (cf. Supplementary Table S3 Supplementary Tables S6, S12 , S14, and S15. 
7739_WGS_V4_X Ten (60x) Figure S17 . Influence of GC content on the mean read depth and coverage of RefSeq exons in whole genome sequencing (WGS Figure S20 . Percentages of non-reference (mutant) alleles for heterozygous indels called in our gVCF files generated by the same in-house bioinformatics pipeline for all six platform-vendor combinations. Fraction of biallelic non-reference alleles for shared heterozygous variants within the platforms' designed target region and 50-bp flanking sequences achieving ≥20 reads and >30 quality scores by all six platform-vendor combinations are displayed. Variant positions with more than one different non-reference allele (non-biallelic) as well as variant calls with alternative allele percentages outside 10-90% were excluded. Dashed lines indicate an interval within which 95% of the percentage values of non-reference alleles lie (calculated according to the Student's t distribution as the mean of n percentage values ± critical t value (t crit,n-1 ) × SD using n = 5'645, t crit = 1.960). Figure S21 . Differences in variant calling among platforms (Agilent, NimbleGen, Illumina) and vendors (V1-V4) in our gVCF files generated by the same in-house bioinformatics pipeline. Displayed are the relative proportions of heterozygous variant positions either called (heterozygous) or missed (no nonreference allele) by only one of the three platforms (i.e. called as heterozygous by only one or by all but one platform). Genomic positions within the platforms' designed target regions and 50-bp flanking sequences which achieved ≥20 reads and >30 quality scores for all six platform-vendor combinations were considered for this analysis (cf. Supplementary Table S3 ), thereby excluding variant positions with more than one different alternative allele (non-biallelic) or heterozygous calls with allele fractions outside the range of 10-90%. For values see Supplementary Table S28 . Error bars indicate 95% confidence intervals. Deletion WGS 60× X Ten (V4) Figure S23 . Deletion identification using WGS and WES. The genomic region of a deletion (sample 7739) detected by array CGH (4.2M NimbleGen aCGH, data not shown) is displayed by the Integrative Genomics Viewer (IGV) for both WGS and WES data. WGS was performed by V4 (HiSeq X Ten) and V1 at 60× as well as by V3 and V4 at 30×, whereas WES was carried out by V2 using Agilent SureSelect v5+UTR at 100×. For WES data, coverage track is shown only. Red dashed lines indicate level of highest read depth of exon 8. Display range of coverage tracks are set to 0-100 (V4 HiSeq X Ten), 0-60 (V1), 0-50 (V4), and 0-40 (V3) reads for WGS and 0-350 for WES.
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1.00 ± 0.41
1.00 ± 0.44
1.00 ± 0.37 1.00 ± 0.43
1.00 ± 0.43 1.01 ± 0.38 Note that the distribution of relative base counts for 280_NimbleGen_V1 and 7739_Illumina_V1 differ from the patterns observed in the other two exemplified samples for the same platform-vendor combination. Solid line indicates mean and dashed lines indicate an interval within which 95% of the relative base counts lie (calculated according to the Student's t distribution as the mean of n values ± critical t value (t crit,n-1 ) × SD using n = 108'845 and 21'769 in (A) and (B), respectively, t crit = 1.960). Values per sample and the number of dots with relative base counts >3 not shown in this figure are given in Supplementary Table S29 . Figure S24 ) of sample 7739 and four additional DNA samples plotted against the GC content of the respective exon. WGS was performed by V4 at 60× on a HiSeq X Ten system. Solid line indicates mean and dashed lines indicate an interval within which 95% of the relative base counts lie (calculated according to the Student's t distribution as the mean of n values ± critical t value (t crit,n-1 ) × SD using n = 108'845, t crit = 1.960). Nine dots have relative base counts >3 and are therefore not shown in this figure. 
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Illumina_V4 wild-type heterozygous deletion homozygous deletion duplication 1.00 ± 0.44 Figure S26 . Relative WES base counts of 182 RefSeq exons with copy numbers known from array CGH (black/coloured dots according to the genotype given in Supplementary Table S21 ). For all six platform-vendor combinations, base counts are normalised by means of 21'769 RefSeq exons (Supplementary Figure S24 ) and plotted relative to the corresponding base counts of sample 326 and against the GC content of the respective exon. Relative WES base counts of ~160'000 RefSeq exons not used for normalisation with at least one base covered at 20× and a total base count of ≥1'000 in sample 326 are included and indicated (grey dots). Solid line indicates mean of the relative base counts of exons with two copies (wild-type, black dots) and dashed lines indicate an interval within which 95% of the relative base counts of these exons lie (calculated according to the Student's t distribution as the mean of n values ± critical t value (t crit,n-1 ) × SD using n = 541, 549, 533, 534, 566, and 520 for Agilent_V1, Agilent_V2, NimbleGen_V1, NimbleGen_V3, Illumina_V1, and Illumina_V4, respectively and t crit = 1.960). Values per sample and the number of dots with relative base counts >3 not shown in this figure are given in Supplementary Table S30 .
Page 23 Table S1. Panel of eight selected genes and number of variants detected by Sanger sequencing in these genes in at least one of the six DNA samples used in this study. The numbers of heterozygous SNVs and indels (SNVs/indels) are summarized for each gene (all) as well as given for our region of interest (ROI, coding exons with -50-bp and +20-bp flanking intronic sequences) and UTR separately.
Number of SNVs/indels Genes (NM number)
All No filtered and recalibrated VCF file available *Information on bioinformatics pipelines of vendors V1-V4 are according to supplied documentation and information stored in provided filtered VCF files. Note that for the different analysis steps, quality and quantity of information on both data analysis pipeline and platform metrics differed among vendors. Most information on data analysis workflow was provided by V1 and V2, whereas information from V3 was only obtained upon request and the report of V4 was rather poor. **Marked duplicates were removed from the provided/generated BAM files using Picard v1.108/1.118 MarkDuplicates. ***Nomenclature according to VCF v4.1 format. ****V4 defined on-target reads as reads within platforms' designed target region and 100-bp flanking sequences, number of aligned reads is given as total number of mapped unique reads without restriction on on-target reads (cf. Figure 1A , Supplementary Figure S13 , and Supplementary Tables S5 and S24) Table S7 . Enrichment efficiency of the three enrichment platforms performed by the same vendor (V1) for intronic sequences (regions) in our region of interest (RefSeq coding exons and -50-bp and +20-bp flanking intronic sequences). Table S13 . Enrichment efficiency of the three enrichment platforms performed by different vendors (V2-V4) for intronic sequences (regions) in our region of interest (RefSeq coding exons and -50-bp and +20-bp flanking intronic sequences). 44  280  326  2905  7344  7739  Mean  Total number of regions 199'107 199'107 199'107 199'107 199'107 199'107 199 197'564 197'564 197'564 197'564 197'564 197'564 197 
Agilent_V2_RefSeq_coding_-50 bp
42 (2) 16 (2) 6 (0) 1 (0) 6 (0) 2 (0) 0 (0) 0 (0) 7344 39 (2) 18 (1) 8 (0) 1 (1) 6 (1) 3 (0) 1 (0) 0 (0) 7739 17 (3) 6 (0) 2 (0) 2 (0) 1 (0) 0 (0) 0 (0) 0 (0) Total 125 (11) 49 (5) 17 (0) 7 (2) 20 (2) 7 (0) 3 (0) 0 (0) 0  0  0  2  1  3  0  0  0  2  0  0  0  0  0  0  0  0  True results  30  30  30  30  30  30  26  26  30  30  11  11  11  11  11  11  11  11  False and NA 
Untranslated regions (UTR) Total SNVs
SNVs in designed target region SNVs in designed target region of all three platforms Heterozygous AG (V1) AG (V2) NG (V1) NG (V3) ILL (V1) ILL (V4) AG (V1) AG (V2) NG (V1) NG (V3) ILL (V1) ILL (V4) AG (V1) AG (V2) NG (V1) NG (V3) ILL (V1) ILL (V4) 1/6 samples 2/3 2/3 2/2 2/3 3/3 2/3 2/2 2/2 2/2 2/3 3/3 2/3 2/2 2/2 2/2 2/2 2/2 1/2 2/6 samples 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 3/6 samples Table S21 . Genomic regions (182 exons) with copy numbers known from array CGH (highlighted in Supplementary Figure S26 ). Table S22 . Total raw read counts reported by the four vendors (V1-V4). NimbleGen  Illumina  V1  V2  V1  V3  V1  V4  44 154 '666'636 188'901'528 223'738'732 164'277'220 106'883'310 68'141'762 280 219'518'670 173'953'326 159'813'888 199'864'124 115'773'968 57'109'004 326 137'556'636 173'729'966 154'276'308 142'064'946 95'556'070 71'901'946 2905 130'559'938 144'762'290 178'017'756 149'900'120 133'200'476 72'876'912 7344 172'323'066 172'157'056 167'946'762 195'763'608 122'058'350 70'667'504 7739 151'440'766 178'561'090 190'473'376 Table S3 ). Table S25 . Enrichment and detection of non-reference (alternative) alleles in VCF files provided by vendors (V1-V4). Fraction (%) of nonreference (alternative) alleles for shared sequence variants targeted by each platform and located within RefSeq coding exons completely (100%) covered with ≥20 reads by all six platform-vendor combinations. Analysis was performed using filtered and recalibrated (V1), filtered only (V2) or unfiltered VCF files (V3 andV4) provided by vendor V1 using the same data analysis workflow for all three platforms ensuring best comparability and vendors V2-V4 with different data analysis settings as specified in Supplementary Table S3 . Table S26 . Enrichment and detection of non-reference (alternative) alleles in gVCF files generated by the same in-house bioinformatics pipeline. Fraction (%) of alternative alleles for shared sequence variants within the platforms' designed target region and 50-bp flanking sequences achieving ≥20 reads and >30 quality scores by all six platform-vendor combinations. Table S27 . Array CGH data for three DNA samples (44, 7344, and 7739) . Common coding SNVs of NimbleGen CGH/LOH array within designed target region and exons completely covered at ≥20 reads by WES performed by all platforms and vendors compared to WES variant calls (unfiltered VCF files provided by vendors, cf. Supplementary Table S3 ). Supplementary Figure S24 lie (calculated according to the Student's t distribution as the mean of n values ± critical t value (t crit,n-1 ) × SD using n = 21'769 and 108'845 for individual and the total of five samples, respectively, t crit = 1.960). The number of dots with relative base counts >3 and thus not shown in Supplementary Figure S24 is given in parentheses.
Chr

Sample Agilent
SNVs and indels
44 280 326* 2905 7344 7739 Total** Agilent_V1
1.01±0.34 (1) 1.01±0.32 (0) 1.00±0.00 (0) 1.01±0.34 (1) 1.01±0.32 (0) 1.01±0.33 (0) 1.01±0.33 (2) Agilent_V2
1.00±0.28 (1) 1.01±0.28 (0) 1.00±0.00 (0) 1.01±0.29 (1) 1.01±0.28 (0) 1.01±0.28 (0) 1.01±0.28 (2) NimbleGen_V1
1.00±0.37 (2) 1.00±0.41 (2) 1.00±0.00 (0) 1.00±0.37 (2) 1.00±0.38 (2) 1.00±0.43 (2) 1.00±0.39 (10) NimbleGen_V3
1.02±0.41 (1) 0.99±0.46 (2) 1.00±0.00 (0) 1.01±0.41 (1) 1.01±0.38 (0) 1.03±0.43 (0) 1.01±0.42 (4) Illumina_V1
1.00±0.41 (1) 1.00±0.44 (0) 1.00±0.00 (0) 1.00±0.43 (1) 1.00±0.46 (0) 1.01±0.38 (0) 1.00±0.42 (2) Illumina_V4
1.02±0.42 (2) 1.04±0.46 (0) 1.00±0.00 (0) 1.03±0.42 (2) 1.02±0.42 (0) 1.03±0.43 (0) 1.03±0.43 (4) * Base counts are calculated relative to this sample (i.e. 1.00±0.00 (0) is expected/trivial), **excluding sample 326. Table S30 . Intervals within which 95% of the relative base counts of wild-type RefSeq exons (two copies, displayed as black dots in Supplementary Figure S26 ) lie (calculated according to the Student's t distribution as the mean of n values ± critical t value (t crit,n-1 ) × SD using the n values indicated in the table and the corresponding t crit values). The number of dots with relative base counts >3 (out of a total of ~800'000 dots with relative base counts derived from ~160'000 RefSeq exons of five DNA samples, "grey dots") and thus not shown in Supplementary Figure S26 is given in parentheses. 
